Evidence map›Paper›PMID 39741813›Full record

ArticleACS omega2024

Miniature Mass Spectrometry for Point-of-Care Testing the GPIIb/IIIa Inhibitor Tirofiban during Perioperative Period of Percutaneous Coronary Intervention.

Dongchen Zhou, Jiahui Wu, Qingcheng Wang, Yong Liu, Shiqi Wang, Weizong Zhang, Yunfeng Zhang, Huizhi Ding, Yunfei Shao, Haixing Wang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dongchen ZhouDepartment of Cardiology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Jiahui WuLaboratory of Food Nutrition and Clinical Research, Zhejiang Gongshang University, Hangzhou 310018, China.
Qingcheng WangLaboratory of Food Nutrition and Clinical Research, Zhejiang Gongshang University, Hangzhou 310018, China.
Yong LiuKey Laboratory of Drug Monitoring and Control of Zhejiang Province, National Narcotics Laboratory Zhejiang Regional Center, Hangzhou 310053, China.
Shiqi WangDepartment of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo 315000, China.
Weizong ZhangFirst People's Hospital of Linping District, Hangzhou 311100, China.
Yunfeng ZhangInstitute of Forensic Science, Ministry of Public Security, Beijing 100038, China.
Huizhi DingDepartment of Cardiology, Sanmen People's Hospital, Taizhou 317100, China.
Yunfei ShaoDepartment of Cardiology, Sanmen People's Hospital, Taizhou 317100, China.
Haixing WangKey Laboratory of Drug Monitoring and Control of Zhejiang Province, National Narcotics Laboratory Zhejiang Regional Center, Hangzhou 310053, China.
Qing ShenPanvascular Diseases Research Center, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, China.ORCID https://orcid.org/0000-0002-9418-0182

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precise administration of tirofiban must be carefully considered to achieve the best treatment efficacy and maximize safety for patients. Herein, a paper spray ionization (PSI) linear ion trap (LIT) portable mass spectrometer (pMS) based point-of-care testing (POCT) technique was developed for on-site sampling, clinical testing, and immediate analysis of tirofiban blood drug concentrations. The results showed that tirofiban formed a significant and stable parent ion peak at

Identifiers

PMID39741813
PMCPMC11683618

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.